Subcutaneous alemtuzumab may be useful in the treatment of steroid-refractory acute graft-versus-host disease

被引：0
|
作者：
Gomez-Almaguer, David [1 ]
Ruiz-Arguelles, Guillermo J. [2 ]
Gonzalez-Llano, Oscar [1 ]
Guttierez-Aguire, Homero C. [1 ]
Cantu-Rodriguez, Olga G. [1 ]
Jaime-Perez, Jose C. [1 ]
Giralt, Sergio [3 ]
机构：
[1] Hosp Univ, Monterrey, Mexico
[2] Ctr Hematol & Med Interna Puebla, Puebla, Mexico
[3] MD Anderson Canc Ctr, Houston, TX USA
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.2983.2983
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2983
引用
收藏
页码：876A / 876A
页数：1
相关论文
共 50 条
  • [31] Vedolizumab for treatment of steroid-refractory lower gastrointestinal acute graft-versus-host disease
    Alexander Coltoff
    Guido Lancman
    Sara Kim
    Amir Steinberg
    Bone Marrow Transplantation, 2018, 53 : 900 - 904
  • [32] Fetal membrane cells for treatment of steroid-refractory acute graft-versus-host disease
    Kaipe, H.
    Erkers, T.
    Nava, S.
    Uzunel, M.
    Iwarsson, E.
    Conrad, R.
    Westgren, M.
    Mattsson, J.
    Ringden, O.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S175 - S176
  • [33] Fetal Membrane Cells for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease
    Ringden, Olle
    Erkers, Tom
    Nava, Silvia
    Uzunel, Mehmet
    Iwarsson, Erik
    Conrad, Reka
    Westgren, Magnus
    Mattsson, Jonas
    Kaipe, Helen
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S141 - S142
  • [34] Infliximab for the treatment of severe steroid-refractory acute graft-versus-host disease.
    Patriarca, F
    Sperotto, A
    Prosdocimo, S
    Skert, C
    Morreale, G
    Dini, G
    Bandini, G
    Milone, G
    Corradini, P
    Peccatori, J
    Fanin, R
    Bosi, A
    Bacigalupo, A
    BLOOD, 2003, 102 (11) : 451B - 451B
  • [35] Etanercept as Treatment of Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric Patients
    Faraci, Maura
    Calevo, Maria Grazia
    Giardino, Stefano
    Leoni, Massimiliano
    Ricci, Erica
    Castagnola, Elio
    Lanino, Edoardo
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (04) : 743 - 748
  • [36] Fetal Membrane Cells for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease
    Ringden, Olle
    Erkers, Tom
    Nava, Silvia
    Uzunel, Mehmet
    Iwarsson, Erik
    Conrad, Reka
    Westgren, Magnus
    Mattsson, Jonas
    Kaipe, Helen
    STEM CELLS, 2013, 31 (03) : 592 - 601
  • [37] Vedolizumab for treatment of steroid-refractory lower gastrointestinal acute graft-versus-host disease
    Coltoff, Alexander
    Lancman, Guido
    Kim, Sara
    Steinberg, Amir
    BONE MARROW TRANSPLANTATION, 2018, 53 (07) : 900 - 904
  • [38] Mycophenolate mofetil for the treatment of acute and chronic steroid-refractory graft-versus-host disease
    Marta Krejci
    Michael Doubek
    Tomas Buchler
    Yvona Brychtova
    Jiri Vorlicek
    Jiri Mayer
    Annals of Hematology, 2005, 84 : 681 - 685
  • [39] Phase I Study of Alemtuzumab for Therapy of Steroid-Refractory Chronic Graft-versus-Host Disease
    Nikiforow, Sarah
    Kim, Haesook T.
    Bindra, Bhavjot
    McDonough, Sean
    Glotzbecker, Brett
    Armand, Philippe
    Koreth, John
    Ho, Vincent T.
    Alyea, Edwin P., III
    Blazar, Bruce R.
    Ritz, Jerome
    Soiffer, Robert J.
    Antin, Joseph H.
    Cutler, Corey S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (05) : 804 - 811
  • [40] A Phase I Study of Alemtuzumab Dosing for Steroid-Refractory Chronic Graft-Versus-Host Disease
    Nikiforow, Sarah
    Kim, Haesook T.
    Bindra, Bhavjot
    McDonough, Sean
    Glotzbecker, Brett
    Armand, Philippe
    Koreth, John
    Ho, Vincent T.
    Alyea, Edwin P., III
    Ritz, Jerome
    Soiffer, Robert J.
    Antin, Joseph H.
    Cutler, Corey
    BLOOD, 2012, 120 (21)
12345